首页> 外文OA文献 >Oral appliance in sleep apnea treatment: respiratory and clinical effects and long-term adherence
【2h】

Oral appliance in sleep apnea treatment: respiratory and clinical effects and long-term adherence

机译:口服睡眠呼吸暂停治疗:呼吸系统疗效和长期粘附

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

There is an increasing tendency to use oral appliance (OA) as an alternative treatment for sleep apnea. Here we report the long-term adherence and clinical effects of OA therapy. All sleep apnea patients treated at the Department of Dentistry between the years 2006 and 2013 (n = 1208) were reviewed. A questionnaire about OA adherence, asthma symptoms (Asthma Control Test (TM), ACT), and general health was sent to all patients who continued OA therapy after the 1-month follow-up visit (n = 811). OA was adjusted to obtain at least 70 % of the maximal protrusion of the mandible. The response rate was 37.4 % (99 women, 204 men). The mean +/- SD age and BMI were 58.7 +/- 10.3 years and 27.3 +/- 4.0 kg/m(2), respectively. During the mean follow-up period of 3.3 years, there was no significant variation in BMI. Forty-one patients abandoned OA therapy yielding an adherence rate of 86 %. Ninety-seven percent of patients used OA a parts per thousand yen4 h/day, and the mean daily use was 7.2 +/- 1.1 h. The ACT score improved with OA use from 16.0 +/- 5.9 to 20.1 +/- 3.8 (p = 0.004), indicating better asthma control. The apnea and hypopnea index decreased significantly from 27 +/- 19 at baseline to 10 +/- 10 with OA therapy (p = 0.001). After a 1-month trial period, the long-term adherence to oral appliance was good. OA therapy decreased apneas and hypopneas significantly, and its long-term use was associated with an improvement in respiratory and asthma symptoms.
机译:使用口服用具(OA)作为睡眠呼吸暂停的替代治疗越来越大。在这里,我们报告了OA治疗的长期依从性和临床影响。审查了2006年和2013年(N = 1208)之间牙科部门治疗的所有睡眠呼吸暂停患者。关于OA粘附,哮喘症状(哮喘控制测试(TM),法案)和一般健康的调查问卷向所有持续在1个月的后续访问后持续治疗的所有患者(n = 811)。调整OA以获得至少70%的下颌骨突起。响应率为37.4%(99名妇女,204名男子)。平均+/- SD年龄和BMI分别为58.7 +/- 10.3岁,分别为27.3 +/- 4.0千克/ m(2)。在平均随访时间为3.3岁,BMI没有显着变化。四十一名患者被遗弃的OA治疗产生86%的粘附率。百分之九十七名患者使用OA零百万日元,平均每日使用量为7.2 +/- 1.1小时。 ACT评分随从OA使用的oa使用,从16.0 +/- 5.9到20.1 +/- 3.8(p = 0.004),表明哮喘更好。呼吸暂停和缺氧性指数在基线27 +/- 19下显着降低至10 +/- 10,OA疗法(P = 0.001)。经过1个月的试用期后,长期坚持口服家电良好。 OA疗法显着降低了呼吸暂停和低钠,其长期使用与呼吸系统和哮喘症状的改善有关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号